Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer

[1]  Tae Yong Kim,et al.  Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit , 2016, Endocrinology and metabolism.

[2]  Jee Soo Kim,et al.  Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence , 2016, Head & neck.

[3]  C. Ki,et al.  Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques , 2016, Cancer medicine.

[4]  Tae Yong Kim,et al.  Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010 , 2014, Endocrinology and metabolism.

[5]  N. Besic,et al.  Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland , 2014, World Journal of Surgical Oncology.

[6]  David F. Schneider,et al.  Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden. , 2014, The Journal of surgical research.

[7]  J. Jonklaas,et al.  Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. , 2014, Thyroid : official journal of the American Thyroid Association.

[8]  J. Shah,et al.  The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. , 2012, Thyroid : official journal of the American Thyroid Association.

[9]  Yoo Seok Jung,et al.  Preoperative Serum Thyroglobulin as a Useful Predictive Marker to Differentiate Follicular Thyroid Cancer from Benign Nodules in Indeterminate Nodules , 2012, Journal of Korean medical science.

[10]  A. Pinchera,et al.  Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. , 2012, The Journal of clinical endocrinology and metabolism.

[11]  N. Besic,et al.  Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland , 2012, Journal of surgical oncology.

[12]  M. Guerrero,et al.  Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. , 2010, American journal of surgery.

[13]  Jandee Lee,et al.  Differentiated Thyroid Carcinoma Presenting With Distant Metastasis at Initial Diagnosis: Clinical Outcomes and Prognostic Factors , 2010, Annals of surgery.

[14]  M. Hočevar,et al.  Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. , 2008, Medical science monitor : international medical journal of experimental and clinical research.

[15]  R. Tsang,et al.  Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis , 2007, Cancer.

[16]  L. Ceriani,et al.  Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy , 2007, Clinical endocrinology.

[17]  T. Pilli,et al.  Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer. , 2005, Thyroid : official journal of the American Thyroid Association.

[18]  Kenneth F Schulz,et al.  Refining clinical diagnosis with likelihood ratios , 2005, The Lancet.

[19]  K. Ain,et al.  Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. , 2004, Clinics in laboratory medicine.

[20]  Stephanie L. Lee,et al.  A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[21]  J. Shah,et al.  Differentiated thyroid cancer presenting initially with distant metastasis. , 1997, American journal of surgery.

[22]  D. Altman,et al.  Statistics Notes: Diagnostic tests 2: predictive values , 1994, BMJ.

[23]  B. Caillou,et al.  Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. , 1986, The Journal of clinical endocrinology and metabolism.

[24]  G. Guiraudon,et al.  Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment , 1984, Cancer.

[25]  W. Beierwaltes,et al.  Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  M. Schlumberger,et al.  Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. , 1980, The Journal of clinical endocrinology and metabolism.

[27]  uller,et al.  Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. , 1975, The Journal of clinical investigation.

[28]  M. Schlumberger,et al.  Management of advanced medullary thyroid cancer. , 2016, The lancet. Diabetes & endocrinology.

[29]  S. Larson,et al.  Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. , 2000, Thyroid : official journal of the American Thyroid Association.

[30]  J. Høie,et al.  Distant metastases in papillary thyroid cancer. A review of 91 patients , 1988, Cancer.

[31]  J. A. Gray.  Predictive values. , 1987, The Practitioner.